Generic Drug Analysis & Statistics, August 2013 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

871-900 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Generics in Asia-Pacific, MarketLine

Generics in Asia-Pacific, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Asia
Generics in Belgium, MarketLine

Generics in Belgium, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Belgium
Generics in China, MarketLine

Generics in China, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : China
Generics in Europe, MarketLine

Generics in Europe, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Europe
Generics in France, MarketLine

Generics in France, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : France
Generics in Germany, MarketLine

Generics in Germany, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Germany
Generics in Italy, MarketLine

Generics in Italy, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : Italy
Generics in Japan, MarketLine

Generics in Japan, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Japan
Generics in Spain, MarketLine

Generics in Spain, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : Spain
Generics in the Netherlands, MarketLine

Generics in the Netherlands, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The ...

  • Industries : Generic Drug
  • Countries : Netherlands
Generics in Canada, MarketLine

Generics in Canada, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Canada
Global Generics, MarketLine

Global Generics, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : World
Biologics and Biosimilars World Markets

Biologics and Biosimilars World Markets

  • $ 3 400
  • Industry report
  • August 2013
  • by TriMark Publications

Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating ...

  • Industries : Pharmaceutical, Biotechnology, Drug and Medication, Biopharmaceutical
  • Countries : United States, North America, World
Sigma International General Medical Apparatus L.L.C. - Medical Equipment - Deals and Alliances Profile

Sigma International General Medical Apparatus L.L.C. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Sigma International General Medical Apparatus L.L.C. (Sigma) is a manufacturer of large volume infusion pumps. It is a part of Baxter International Inc. The company offers infusion systems that ...

EMS SA in Consumer Health (Brazil)

EMS SA in Consumer Health (Brazil)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

EMS plans to reach the leading position amongst all the consumer health companies in the country. In order to accomplish this goal, it is expected to continue to invest in generics, by launching new products ...

  • Industries : Drug and Medication
  • Countries : South Africa, Saudi Arabia
Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2013-2023

  • $ 2 548
  • Industry report
  • July 2013
  • by Visiongain

Report Details Generics companies - assess products, developments, and revenue prospects What does the future hold for makers of generic drugs? Visiongain's updated report shows you their prospects to ...

  • Industries : Generic Drug
Cancer Generics Market Outlook 2017

Cancer Generics Market Outlook 2017

  • $ 1 000
  • Industry report
  • July 2013
  • by RNCOS

The National Cancer Institute has stated that almost half of the population born today will be diagnosed with cancer at some point during their lifetime. With global cancer incidence rising to almost 13 ...

  • Industries : Pharmaceutical, Pathology, Drug and Medication
  • Countries : World
Biogaran, Laboratoires in Consumer Health (France)

Biogaran, Laboratoires in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires Biogaran is expected to maintain its focus on its core business activities: the development, manufacturing, marketing and distribution of generics. With the reinforcement of “Third party ...

  • Industries : Generic Drug, Healthcare
  • Countries : France
Biosimilar Defensive Plays – Assessing the options

Biosimilar Defensive Plays – Assessing the options

  • $ 495
  • Industry report
  • June 2013
  • by Firstword Pharma

Although biological therapeutics have developed into an increasingly valuable segment of the pharmaceutical market, the commercial impact of biosimilar products has, to date, been fairly insignificant. ...

  • Industries : Generic Drug
  • Countries : United States
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

  • $ 2 995
  • Industry report
  • May 2013
  • by Global Data

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, ...

  • Industries : Generic Drug
  • Countries : Europe, India, World, China
Alzheimer's Drugs Market, 2012 - 2017

Alzheimer's Drugs Market, 2012 - 2017

  • $ 1 699
  • Industry report
  • May 2013
  • by Roots Analysis Private Ltd.

Alzheimer’s disease is a neurodegenerative disease of the brain which leads to loss of memory and cognitive functions. With ageing world population, the number of patients suffering from Alzheimer’s ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Europe, World, Japan
Orifarm A/S in Consumer Health (Denmark)

Orifarm A/S in Consumer Health (Denmark)

  • $ 153
  • Company report
  • May 2013
  • by Euromonitor International

Orifarm A/S is a fast growing supplier of parallel imported and generic pharmaceuticals. Orifarm’s strategic focus is to strengthen its position as the leading supplier of parallel imports and generic ...

  • Industries : Pharmaceutical, Healthcare, Generic Drug
  • Countries : Denmark
Biosimilars And Follow-On Biologics: World Market 2013-2023

Biosimilars And Follow-On Biologics: World Market 2013-2023

  • $ 2 548
  • Industry report
  • April 2013
  • by Visiongain

Report Details Biosimilar drugs - discover trends and areas with highest revenue potential Do you want to find the sales potential of biosimilars? Visiongain's updated report gives you revenue predictions ...

  • Industries : Biopharmaceutical
  • Countries : Europe, World
Branded Generics: Strategies and Tactics for Winning in Latin America

Branded Generics: Strategies and Tactics for Winning in Latin America

  • $ 1 995
  • Industry report
  • April 2013
  • by Firstword Pharma

Introduction It’s a $66 billion market—and getting bigger every year. The time is ripe for action. Yet for all the appeal and potential returns of investing in Latin America’s burgeoning branded ...

  • Industries : Generic Drug
  • Countries : United States
PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013 Summary "PharmaLeaders: Generic Manufacturers Benchmark Report ...

  • Industries : Generic Drug
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013

  • $ 2 995
  • Industry report
  • March 2013
  • by Global Data

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Summary GlobalData’s "PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013" report, provides ...

  • Industries : Generic Drug
  • Countries : World, India
Biosimilars in Emerging Markets

Biosimilars in Emerging Markets

  • $ 665
  • Industry report
  • March 2013
  • by Firstword Pharma

What are the implications for regulators, biosimilar companies and branded manufacturers? There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing ...

  • Industries : Generic Drug
  • Countries : Brazil, South Korea
The 2013-2018 Outlook for Over-The-Counter Generic Drugs in the United States

The 2013-2018 Outlook for Over-The-Counter Generic Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for over-the-counte ...

  • Industries : Generic Drug
  • Countries : United States
The 2013-2018 Outlook for Generic Drugs in the United States

The 2013-2018 Outlook for Generic Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic drugs ...

  • Industries : Generic Drug
  • Countries : United States
The 2013-2018 Outlook for Generic Prescription Drugs in the United States

The 2013-2018 Outlook for Generic Prescription Drugs in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for generic prescription ...

  • Industries : Generic Drug
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.